期刊文献+

瑞舒伐他汀对大鼠颈动脉球囊损伤后内膜增生及线粒体融合素2表达的影响 被引量:7

Effects of Rosuvastatin on Neointimal Hyperplasia and Mitofusin 2 Expression After Carotid Artery Balloon Injury in Rats
下载PDF
导出
摘要 目的研究瑞舒伐他汀对大鼠颈动脉球囊损伤后内膜增生及线粒体融合素2表达的影响。方法选取雄性Wistar大鼠32只,随机分为假手术组、模型组、瑞舒伐他汀1组和瑞舒伐他汀2组,每组8只。瑞舒伐他汀1组于术前3天开始每日给予瑞舒伐他汀5 mg/kg灌胃,瑞舒伐他汀2组每日给予20 mg/kg灌胃,模型组以蒸馏水灌胃,随后制备颈动脉球囊损伤模型。建模后14天处死大鼠取颈动脉,HE染色行组织形态学观察,测量内膜/中膜面积比;免疫组织化学、免疫印迹法检测线粒体融合素2和增殖细胞核抗原的表达;依文思蓝染色观察血管内皮修复。结果与假手术组比较,模型组、瑞舒伐他汀1组和瑞舒伐他汀2组血管内膜增生,内膜/中膜面积比值显著增加(P<0.01),增殖细胞核抗原阳性细胞比值显著增加(P<0.01),线粒体融合素2表达显著降低(P<0.01);与模型组比较,瑞舒伐他汀1组、瑞舒伐他汀2组血管内膜/中膜面积比值显著降低(P<0.01),增殖细胞核抗原阳性细胞比值显著降低(P<0.01),线粒体融合素2表达显著增高(P<0.05),且瑞舒伐他汀2组较瑞舒伐他汀1组变化更显著(P<0.01)。依文思蓝染色显示,瑞舒伐他汀1组、瑞舒伐他汀2组再内皮化程度显著好于模型组(P<0.05)。结论瑞舒伐他汀可抑制大鼠颈动脉球囊损伤后内膜增生,同时促进内皮修复,其作用可能与上调线粒体融合素2表达有关。 Aim To investigate the effects of rosuvastatin on neointimal hyperplasia and mitofusin 2 (Mfn2) expression after carotid artery balloon injury in rats. Methods Thirty-two male Wistar rats were randomly divided into sham-operated group, model group, rosuvastatin group 1 and group 2. The rats in the two rosuvastatin groups were given rosuvastatin 5 mg/kg or 20 mg/kg daily, respectively. The rats in the model group and the two rosuvastatin groups were induced neointimal hyperplasia by carotid artery balloon injury. After the rats were sacrificed at day 14, HE staining was used to observe the change of vascular morphology. Immunohistochemistry staining and Western blot were performed to measure the expression of Mfn2 and proliferating cell nuclear antigen (PCNA). Evans blue staining was used to measure the reendothlialized area. Results On the 14 th day after operation, compared with the model group, the neointimal area and intimal/media area ratio were significantly decreased in the two rosuvastatin groups (P〈0.01). Mfn2 expression was up-regulated in the two rosuvastatin groups (P〈0.01). Rosuvastatin did not inhibit the reendothlialized in the injured carotid arteries. Conclusions Rosuvastatin attenuates neointimal hyperplasia and restenosis in the rat carotid artery balloon injury model, which may be related to up-regulated expression of Mfn2.
作者 周炜 陈曼华
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2013年第5期424-428,共5页 Chinese Journal of Arteriosclerosis
关键词 瑞舒伐他汀 内膜增生 线粒体融合素2 Rosuvastatin Neointimal Hyperplasia Mitofusin 2
  • 相关文献

参考文献13

  • 1Orr AW, Hastings NE, Blackman BR, et al. Complex reg- ulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis [ J ]. J Vasc Res, 2010, 47 (2) : 168-180.
  • 2Davignon J, Mabile L. Mechanisms of action of statins and their pleiotropic effects [ J ]. Ann Endocrinol ( Paris ), 2001,62 (1 Pt2): 101-112.
  • 3Chen KH, Guo XM, Ma DL, et al. Dysregulation of HSG triggers vascular proliferative disorders [ J ]. Nature Cell Bi- ol, 2004, 6 (9): 872-883.
  • 4Preusch MR, Vanakaris A, Bea F, et al. Rosuvastatin re- duces neointima formation in a rat model of balloon injury [J]. EurJ Med Res, 2010, 15 (11) : 461-467.
  • 5Tulis DA. Rat carotid artery balloon injury model [ J ]. Methods Mol Med, 2007, 139: 1-30.
  • 6Tulis DA. Histological and morphometric analyses for rat carotid balloon injury model[ J]. Methods Mol Med, 2007, 139: 31-66.
  • 7van Beusekom HM, Whelan DM, Hofma SH, et al. Long- term endothelial dysfunction is more pronounced after stent- ing than after balloon angioplasty in porcine coronary arter- ies[J]. J Am Coil Cardiol, 1998, 32 (4) : 1 109-117.
  • 8盛莉,叶平,刘永学.他汀类药物防治心肌肥厚的分子机制的研究进展[J].中国动脉硬化杂志,2005,13(5):646-648. 被引量:3
  • 9Inoue T, Node K. Molecular basis of restenosis and novel issues of drug-eluting stents [ J ]. Circ J, 2009, 73 (4) : 615-621.
  • 10Uwatoku T, Shimokawa H, Abe K, et al. Application of nanoparticle technology for the prevention of restenosis af- ter balloon injury in rats[J]. Cire Res, 2003, 92 (7) : e 62-69.

二级参考文献40

  • 1叶平,张铖,伍士敏,刘永学.吡格列酮抑制大鼠心肌肥厚的实验研究[J].中国应用生理学杂志,2005,21(1):35-39. 被引量:8
  • 2王安才,成蓓,谢晓竟,徐浩.阿托伐他汀对自发性高血压大鼠血压和心肌血管紧张素Ⅱ1型和2型受体表达的影响[J].中国动脉硬化杂志,2005,13(1):40-44. 被引量:19
  • 3赵水平,王小清,李全忠,唐汉权.阿托伐他汀及血管紧张素Ⅱ对人体脂肪组织白细胞介素6及Ⅰ型纤溶酶原激活剂抑制物分泌的影响[J].中国动脉硬化杂志,2005,13(1):73-75. 被引量:3
  • 4Chen KH, Wang FQ, Zhang JH, el al. Cloning and expression of a novel cDNA related to Hypertension [ J ]. Clin Med J, 1998,111 (4): 384- 386.
  • 5Chen KH, Guo XM, Ma DL, et al. Dysregulation of HSG triggers vascular proliferative disorders [J ]. Nature Cell Biol, 2004, 6(9) : 872-883.
  • 6Guo XM, Chen KH, Guo YH, et al. Mitofusin 2 triggers vascular smooth muscle cell apoptosis via mitochondrial death pathway [ J ]. Circ Res, 2007, 101(11): 1 113-122.
  • 7Neuspiel M, Zunino R, Gangaraja S, et al. Activated mitofusin 2 signals mitochondrial fusion,interferes with Bax activation, and reduces susceptibility to radical induced depolarization [ J ]. J Biol Chem, 2005, 280 ( 26 ) : 25 060-070.
  • 8Huang PW, Yu TZ, Yoon YS, et al. Mitochondrial clustering induced by overexpression of the mitochondrial fusion protein Mfn2 causes mitochondrial dysfunction and cell death[ J ]. Euro J Cell Biol, 2007, 86 (6) : 289- 302.
  • 9De Brito OM, Seorrano L. Mitofusin 2:A Mitoehondria-Shaping Protein with Signaling Roles Beyond Fusion [J]. Antioxid Redox Signal, 2008, 10(3) : 621-633.
  • 10Carsten M, Thomas L. Mitofusin 2 builds a bridge between ER and mitochondria [J]. Cell, 2008, 135(7) : 1165-167.

共引文献5

同被引文献74

引证文献7

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部